2021C&EN Global EnterpriseRequires access

Single dose of small molecule cures malaria in mice

Bethany Halford

Open publisher page 0 citations

Abstract

A small molecule can cure malaria infections in mice with a single dose, researchers report. They also show that the malaria parasite Plasmodium falciparum has a tough time developing resistance to the compound, known as MMV688533. If shown to be safe and effective in people, MMV688533 could be a powerful weapon in the fight against malaria. Malaria infections and deaths declined between 2000 and 2015 thanks to preventative measures, diagnostics, and therapeutics, but the number of people who get malaria has plateaued since 2016. Malaria parasites in Southeast Asia have developed resistance to the current arsenal of antimalarial drugs, making them ineffective in many cases. This same resistance threatens to become a problem in Africa, where malaria takes the biggest toll. Malaria killed about 409,000 people in 2019, according to the World Health Organization. “It could easily get a lot worse if we lose our first-line drugs,” says malaria researcher

About this research paper

What this paper is about

A small molecule can cure malaria infections in mice with a single dose, researchers report. They also show that the malaria parasite Plasmodium falciparum has a tough time developing resistance to the compound, known as MMV688533. If shown to be safe and effective in people, MMV688533 could be a powerful weapon in the fight against malaria. Malaria infections and deaths declined between 2000 and 2015 thanks to preventative measures, diagnostics, and therapeutics, but the number of people who get malaria has plateaued since 2016. Malaria parasites in Southeast Asia have developed resistance to the current arsenal of antimalarial drugs, making them ineffective in many cases. This same resistance threatens to become a problem in Africa, where malaria takes the biggest toll. Malaria killed about 409,000 people in 2019, according to the World Health Organization. “It could easily get a lot worse if we lose our first-line drugs,” says malaria researcher

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

A small molecule can cure malaria infections in mice with a single dose, researchers report. They also show that the malaria parasite Plasmodium falciparum has a tough time developing resistance to the compound, known as MMV688533. If shown to be safe and effective in people, MMV688533 could be a powerful weapon in the fight against malaria. Malaria infections and deaths declined between 2000 and 2015 thanks to preventative measures, diagnostics, and therapeutics, but the number of people who get malaria has plateaued since 2016. Malaria parasites in Southeast Asia have developed resistance to the current arsenal of antimalarial drugs, making them ineffective in many cases. This same resistance threatens to become a problem in Africa, where malaria takes the biggest toll. Malaria killed about 409,000 people in 2019, according to the World Health Organization. “It could easily get a lot worse if we lose our first-line drugs,” says malaria researcher

Key concepts: Malaria, Death toll, Plasmodium falciparum, Artemisinin, Toll, First line, Plasmodium (life cycle), Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Single dose of small molecule cures malaria in mice — Research Paper | ScholarLens